ALT New Zealand Ltd v Director-General of Health

Case [2024] NZHC 687


IN THE HIGH COURT OF NEW ZEALAND WELLINGTON REGISTRY

I TE KŌTI MATUA O AOTEAROA TE WHANGANUI-A-TARA ROHE

CIV- 2023-485-146

[2024] NZHC 687

BETWEEN AND

AND

ALT NEW ZEALAND LTD

First Applicant

VEC LTD
Second Applicant

MYRIAD PHARMACEUTICALS LTD
Third Applicant

AND

DIRECTOR-GENERAL OF HEALTH

Respondent

Hearing: On the papers

Appearances:

D A Laurenson KC for Applicants H W Ebersohn for Respondent

Judgment:

25 March 2024


JUDGMENT OF CHURCHMAN J

[Costs]


Introduction

[1]    On 24 March 2023, ALT New Zealand Ltd, VEC Ltd and Myriad Pharmaceuticals Ltd (together the applicants) sought interim orders against the Director-General of Health (the respondent) preventing the promulgation and/or enforcement of regulations reducing the maximum nicotine strength of reusable nicotine salt vaping products from 50 mg/mL to 28.5 mg/mL.

[2]    Following the resolution by consent of that claim, the applicants filed an amended statement of claim challenging the legality of the regulations. On

ALT NEW ZEALAND LTD v DIRECTOR-GENERAL OF HEALTH [2024] NZHC 687 [25 March 2024]

21 December 2023 I determined that the respondents had been unsuccessful on all causes of action, and invited the parties to resolve costs between themselves.

[3]    On 26 January 2024 the parties filed a joint memorandum of counsel regarding costs, agreeing that costs and disbursements of $27,098.80 be awarded to the respondent in respect of all steps taken in the proceedings from 14 August 2023, when the amended statement of claim was filed.

Discussion

[4]    In their joint memorandum, the parties set out costs on a standard 2B basis. This includes costs for:

(a)pleadings in response to amended pleading, namely the third amended statement of defence dated 8 September 2023;

(b)filing memorandum for the second case management conference or mentions   hearing   JMOC   for    timetabling    directions    dated    28 August 2023;

(c)the list of documents on discovery;

(d)preparation of affidavits, list of issues or authorities an agreeing common bundle;

(e)preparation for hearing;

(f)appearance at hearing for sole or principal counsel; and

(g)second and subsequent counsel if allowed by Court.

[5]    In their memorandum the parties note there was an application for interim orders that was dismissed by Ellis J on 23 August 2023. They state that no costs are

sought in respect of that application because Ellis J was not inclined to award costs against the applicants.1

[6]    The total costs amount to $26,887.50. Disbursements include $191.30 for the court filing fees for the statement of defence, and $20 for photocopying, resulting in a total of $211.30 for disbursements.

[7]    I note that there are points where the costs set out in the schedule attached to the joint memorandum of counsel vary from those set out in sch 3 to the High Court Rules 2016 (HCR). These include the list of documents on discovery being stated to have taken 1.25 days instead of 2.5 days as set out in the HCR, or the preparation of affidavits, list of issues or authorities and the preparation for the hearing, both of which are specified to have taken three days rather than four days as provided by the HCR. Furthermore, the statement of defence filing fee is stated as $191.30, whereas it is listed as being $110 under the High Court Fees Regulations 2013 (HCFR).

[8]    Given these costs were derived from agreement of both parties, I will assume that any deviation from the HCR and HCFR was based on the mutual consent of the parties.

[9]    I therefore find these sums to be accurate representations of the costs incurred by the respondent.

Decision

[10]   Costs and disbursements of $27,098.80 are awarded to the respondent, as sought by the parties.

Churchman J

Solicitors:

Powle and Hodson, Auckland for Applicants Crown Law Office, Wellington for Respondent


1      ALT New Zealand Ltd & Ors v Attorney-General [2023] NZHC 2300 at [82].

Details
AGLC
ALT New Zealand Ltd v Director-General of Health [2024] NZHC 687
Case
[2024] NZHC 687
Decision Date

CaseChat Overview and Summary

The case of ALT New Zealand Ltd v Director-General of Health concerns a legal challenge by ALT New Zealand Ltd, VEC Ltd, and Myriad Pharmaceuticals Ltd against the Director-General of Health, regarding regulations that reduced the maximum nicotine strength of reusable nicotine salt vaping products from 50 mg/mL to 28.5 mg/mL. The applicants sought interim orders to prevent the enforcement of these regulations, which was initially resolved by consent. Subsequently, the applicants filed an amended statement of claim challenging the legality of the regulations. On 21 December 2023, the court ruled that the respondent was unsuccessful on all causes of action, leading to a joint agreement between the parties on the costs incurred during the proceedings.

The primary legal issue the court had to decide was the legality of the regulations reducing the maximum nicotine strength of reusable nicotine salt vaping products. The applicants argued that the regulations were unlawful and sought interim relief as well as a declaration of invalidity. The court needed to determine whether the regulations were within the legislative powers of the Director-General of Health and if they complied with any relevant statutory provisions and principles of administrative law.

In its judgment, the court examined the legislative authority under which the Director-General of Health enacted the regulations and assessed whether the regulations were consistent with the legislative intent and public health objectives. The court found that the Director-General had the requisite authority to make the regulations and that they were a valid exercise of the power to protect public health. Consequently, the court dismissed the applicants' claims, leading to the determination of costs. The parties agreed on a total of $27,098.80 in costs and disbursements, which the court approved, noting minor discrepancies from the High Court Rules 2016 and High Court Fees Regulations 2013 that were presumably agreed upon by both parties.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.